GNH USA

Europe — EMA

Rybrevant

Rybrevant (amivantamab) is a subcutaneous medication used for targeted therapy in certain cancer treatments. Learn about its uses, effects, and precautions here

Amivantamab

Request sourcing

1
Pack/s

What is Amivantamab?

Rybrevant (amivantamab) is a subcutaneous medication used for targeted therapy in certain cancer treatments. Learn about its uses, effects, and precautions here.

What is Amivantamab used for?

Rybrevant is primarily used in the treatment of specific types of cancer. It works by targeting certain proteins on cancer cells to help slow or stop their growth. Patients often wonder, 'What is Rybrevant used for?' and the answer lies in its role in targeted cancer therapy.

What are the side effects of Amivantamab?

Common effects of Rybrevant may include injection site reactions, fatigue, and nausea. Some patients may also experience muscle or joint pain. These effects can vary from person to person.

What precautions apply to Amivantamab?

Rybrevant should be handled with care and administered as directed by a healthcare professional. It is important to discuss any existing medical conditions or allergies with your doctor before starting treatment.

What does Amivantamab interact with?

Rybrevant may interact with other medications, including certain types of cancer treatments. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently asked questions

What is Rybrevant used for?+
Rybrevant is used in the treatment of specific types of cancer, targeting proteins on cancer cells to help slow or stop their growth.
How is Rybrevant administered?+
Rybrevant is administered subcutaneously, meaning it is injected under the skin.
What are the common side effects of Rybrevant?+
Common side effects may include injection site reactions, fatigue, nausea, and muscle or joint pain.
Can Rybrevant be used with other medications?+
Rybrevant may interact with other medications, so it is important to discuss all current medications with your healthcare provider.
Who manufactures Rybrevant?+
Rybrevant is manufactured by Janssen-Cilag International Nv.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Amivantamab
Route
Subcutaneous Use
Manufacturer
Janssen-Cilag International Nv
Origin
EU

Related products